MedTrace Logo

Age Related Effects Consuming Phaeodactylum Tricornutum

NCT05120791 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-07-06

No results posted yet for this study

Summary

Investigation of the microalgae Phaeodactylum as food with regard to the uptake of omega-3 fatty acids and effects on various blood parameters in relation to age.

Bioavailability and excretion of nutrients and their effects on fatty acid status and inflammatory markers.

Conditions

  • Aging
  • Well Aging

Interventions

DIETARY_SUPPLEMENT

Placebo vegetable bouillon

14 days wahs-out: no fish eating 14 days: no fish eating, the participants eat vegetable bouillon (1,3g)

DIETARY_SUPPLEMENT

microalgae phaeodactylum

14 days wahs-out: no fish eating 14 days: no fish eating, the participants eat vegetable bouillon (1.3g), 2.3g Microalgae Phaeodactylum

DIETARY_SUPPLEMENT

From the Microalgae phaeodactylum the extracted beta-Glucan (especially chrysolaminarin)

14 days wahs-out: no fish eating 14 days: no fish eating, the participants eat vegetable bouillon (1.3g), Beta-Glucan (1.8g)

DIETARY_SUPPLEMENT

A combination of the vegetable bouillon, the microalgae and the beta-Glucan

14 days wahs-out: no fish eating 14 days: no fish eating, the participants eat vegetable bouillon (1.3g), 2.3g Microalgae, Beta-Glucan (1.8g)

Sponsors & Collaborators

  • University of Hohenheim

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-31
Primary Completion
2022-07-31
Completion
2022-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05120791 on ClinicalTrials.gov